KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Gross Margin (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Gross Margin for 13 consecutive years, with 61.52% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 24.0% to 61.52% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 61.38% through Dec 2025, up 46.0% year-over-year, with the annual reading at 61.38% for FY2025, 46.0% up from the prior year.
  • Gross Margin hit 61.52% in Q4 2025 for ClearPoint Neuro, down from 63.2% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 74.36% in Q4 2021 to a low of 52.54% in Q2 2023.
  • Historically, Gross Margin has averaged 62.6% across 5 years, with a median of 62.06% in 2025.
  • Biggest five-year swings in Gross Margin: plummeted -1469bps in 2023 and later skyrocketed 1094bps in 2024.
  • Year by year, Gross Margin stood at 74.36% in 2021, then dropped by -13bps to 65.06% in 2022, then decreased by -9bps to 58.93% in 2023, then rose by 4bps to 61.28% in 2024, then rose by 0bps to 61.52% in 2025.
  • Business Quant data shows Gross Margin for CLPT at 61.52% in Q4 2025, 63.2% in Q3 2025, and 60.29% in Q2 2025.